— Know what they know.
Not Investment Advice

AXNX NASDAQ

Axonics, Inc.
1W: +0.8% 1M: +1.0% 3M: +2.9% 1Y: +24.1% 3Y: +16.7% 5Y: +178.5%
$70.98
Last traded 2024-11-15 — delisted
NASDAQ · Healthcare · Medical - Devices · $3.6B mcap · 50M float · 0.908% daily turnover

Balance Sheet Trends

Total Assets
$720M +9.2% ▲
5Y CAGR: +33.2%
Total Liabilities
$82M -7.7% ▼
5Y CAGR: +23.5%
Shareholders Equity
$638M +11.8% ▲
5Y CAGR: +34.8%
Cash & Investments
$345M -3.4% ▼
5Y CAGR: +17.0%
Total Debt
$28M +202.9% ▲
5Y CAGR: +3.3%
Net Debt
-$77M +66.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$171M$241M$221M$239M$105M
Short-Term Investments$13M$0$0$118M$240M
Cash & ST Investments$184M$241M$221M$357M$345M
Net Receivables$8M$18M$29M$45M$57M
Inventory$16M$63M$65M$56M$80M
Other Current Assets$4M$5M$6M$7M$9M
Total Current Assets$212M$328M$321M$465M$491M
Property, Plant & Equip.$3M$6M$7M$7M$33M
Goodwill & Intangibles$311K$196K$212M$181M$181M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$5M$8M$8M$7M$14M
Total Non-Current Assets$8M$14M$227M$194M$229M
Total Assets$220M$342M$548M$659M$720M
— Liabilities —
Accounts Payable$6M$11M$8M$9M$18M
Short-Term Debt$602K$22M$1M$2M$2M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$3M$5M$11M$38M$13M
Total Current Liabilities$12M$46M$27M$65M$46M
Long-Term Debt$20M$0$0$0$0
Other Non-Current Liab.$0$0$10M$0$0
Total Non-Current Liabilities$25M$9M$39M$24M$37M
Total Liabilities$37M$55M$66M$89M$82M
— Equity —
Common Stock$3K$4K$5K$5K$5K
Retained Earnings-$180M-$234M-$315M-$374M-$380M
Accumulated OCI-$428K-$431K-$7M-$25M-$16M
Total Stockholders Equity$183M$287M$482M$570M$638M
Total Liabilities & Equity$220M$342M$548M$659M$720M
— Key Metrics —
Total Debt$25M$33M$10M$9M$28M
Net Debt-$146M-$208M-$210M-$230M-$77M
Total Investments$13M$0$0$118M$240M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms